Business
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
Highlights Nominees’ Robust Skillsets and Extensive Experience in Healthcare and Biopharmaceuticals Urges Stockholders to Vote “FOR” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company” or “Pacira”), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has sent a letter to
About this update from Pacira Biosciences, Inc.
[{"type":"image","alt":"Pacira BioSciences","displaySize":"","headline":null,"caption":"Pacira BioSciences","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/04e0c8f8e2099937e616269a7f79e669"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oeRpxMnSSfjelY6qFBDpsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/04e0c8f8e2099937e616269a7f79e669","width":300,"height":300},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/oeRpxMnSSfjelY6qFBDpsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/04e0c8f8e2099937e616269a7f79e669","width":300,"height":300}},"lazy":false},{"type":"text","content":"Highlights Nominees’ Robust Skillsets and Extensive Experience in Healthcare and Biopharmaceuticals","length":99,"tagName":"p"},{"type":"text","content":"Urges Stockholders to Vote “FOR” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today","length":112,"tagName":"p"},{"type":"text","content":"BRISBANE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company” or “Pacira”), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has sent a letter to stockholders in connection with its upcoming 2026 Annual Meeting of Stockholders (the “Annual Meeting”), scheduled to be held on June 9, 2026. Stockholders of record as of April 22, 2026 are entitled to vote at the Annual Meeting.","length":518,"tagName":"p"},{"type":"text","content":"Highlights from the letter include:","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Pacira’s highly qualified director nominees are optimal to help guide the Company’s long-term strategy and drive sustainable growth. They possess the skillsets and experience necessary to oversee the execution of our 5x30 strategy, including expertise in executive leadership, mergers and acquisitions, research and development, operations, commercialization, manufacturing and supply chain management.","length":402,"tagName":"p"}]},{"val":[{"type":"text","content":"DOMA’s director candidates are underqualified. They do not have experience serving on public company boards or operating wi...